Drug Profile


Alternative Names: RGH 2957; Yutac

Latest Information Update: 08 Nov 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Gedeon Richter
  • Developer Taiho Pharmaceutical
  • Class Benzoic acids; Class Ic antiarrhythmics; Class IV antiarrhythmics; Small molecules
  • Mechanism of Action Calcium channel antagonists; Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Arrhythmias

Most Recent Events

  • 08 Nov 2006 Discontinued - Phase-II for Arrhythmias in Japan (PO)
  • 09 Nov 1999 A preclinical study has been added to the pharmacodynamics section
  • 08 Aug 1997 Discontinued-II for Arrhythmias in Hungary (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top